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2 Figure S1 Figure S1. Summary of patient statistics. Patient level covariates were recorded and compared between SCZ cases and control samples, separately for each brain region (ACC and DLPFC) and cohort (discovery and validation). In our discovery cohort, a total of 358 unique schizophrenia cases and 380 unique controls were sampled in at least one brain region. A Shapiro-Wilk test was used to assess normality of covariates. If the resulting variable was normally distributed, a two-sided Student's t-test was applied, alternatively a two-sided Wilcoxon rank sum test with continuity correction was implemented. Unless otherwise specified, all comparisons made here include CMC ACC (n control =245, n SCZ =225) and DLPFC (n control =286, n SCZ =254) as well as the NIMG HBCC DLPFC (n control =217, n SCZ =100) samples. (a) Overall RNA editing levels are computed separately for each discrete genic region. (b) RNA editing levels were examined based on a priori defined glutamatergic and serotonergic receptor activity gene sets (GO:009589 and GO:0008066, respectively). For this analysis, RNA editing sites were parsed into two groups: 1) sites which were detected across all >80% of all samples with sufficient base coverage (>20) and examined in down-stream analyses, here termed high-confidence (H.C.) sites; and 2) all remaining sites here termed low-confidence (L.C.) sites. Note that serotonergic receptor activity genes were lowly expressed in these data sets and as a result could not be parsed into a separate H.C. group. (c) Average read coverage/site for each gene indicates high coverage for H.C. glutamatergic sites and low coverage for low-confidence glutamatergic sites; N=60  N=73  N=81  N=45  N=39  N=38  N=59  N=73  N=83  N=46  N=40  N=40  N=56  N=75  N=82  N=46  N=37  N=39  N=57  N=75  N=85  N=48  N=37  N=38  N=58  N=77  N=88  N=48  N=40  N=41 averages are depicted with dashed red line. (d) A smaller fraction of samples with coverage two-fold higher than average (> 10 reads/site) for HTR2C A-E sites (sample numbers labeled in figure) , (e) which were examined for differences in editing ratios between SCZ cases and controls. Reads per kilobase of transcript per million mapped reads (RPKM) expression levels for (f) ADAR1, (g) ADAR2 and (h) ADAR3. Note that ADAR2 expression for HBCC samples is trending opposite to that in CMC samples. For all comparisons, a two-sided Wilcoxon rank sum test with continuity correction was used to test significance between groups. Whisker box plots and violin plots used throughout this figure show median, lower and upper quartiles, and whiskers represent minimum and maximum of the data.
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Figure S3
Figure S3. Overall RNA editing and ADAR expression in macaque samples. (n control =217, n SCZ =100). Genes were labeled 'highly expressed' if they had an average gene expression value across all samples that was in the upper 3 rd quartile. A one-sided Fisher's exact test was used to compute overlap significance and estimated odds-ratios. Overlap analysis also assessed whether genes with differential RNA editing sites displayed differential expression in the CMC (d) ACC and (e) DLPFC samples and (f) NIMH HBCC DLPFC samples. Inset gene symbols indicate genes that harbor differential editing sites and are dysregulated in SCZ. Correlation analysis of RNA editing levels were compared to gene expression levels in three instances: 1) for differentially edited sites relative to their respective gene expression levels; 2) all RNA editing sites relative to their respective gene expression levels; 3) all RNA editing sites relative to gene expression levels other than their respective gene. d! e! f!
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Genes with differential RNA editing" Additionally, we observed that these genes were also predominately underexpressed during the fetal period for the (d) ACC and (e) DLPFC CMC samples and (f) DLPFC HBCC samples, indicating that the developmental expression properties of these genes gradually increase in expression from early prenatal periods and peak during adulthood. All comparisons made here were computed using differential editing results derived from CMC ACC (n control =245, n SCZ =225) and DLPFC (n control =286, n SCZ =254) and HBCC DLPFC (n control =217, n SCZ =100) samples. The overall height of each stack indicates the sequence conservation at that position (measured in bits), whereas the height of symbols within the stack reflects the relative frequency of the corresponding nucleic acid at that position. Subsequently, we tested whether non-differentially edited (non-DE) sites and randomly sampled sites with flanking sequences matched for GC contained enrichment for this same motif. Two sets of randomly sampled sites were chosen to match the exact number of DE and non-DE sites for each brain region. A general enrichment for DE and non-DE RNA editing sites were identified, for which no enrichment was identified for randomly selected sites in the (d) ACC and (e) DLPFC CMC samples and (f) DLPFC HBCC samples. MEME reports an E-value for each motif it finds, which is an estimate of the number of (equally or more interesting) motifs one would expect to find by chance if the letters in the input sequences were shuffled. Motifs with small E-values are very unlikely to be random sequence artifacts.
12 Figure S10 Figure S17. Tissue-specific enhancer enrichment analysis. Genomic coordinates for edSNPs were overlapped with tissue-specific enhancer regions derived from 40 different human tissues; data from the FANTOM project. The regioneR R package was used test overlaps of genomic regions based on permutation sampling. We repeatedly sampled random regions from the genome 1000 times, matching size and chromosomal distribution of the region set under study. By recomputing the overlap with the enhancer features in each permutation, statistical significance of the observed overlap was computed. We observed enrichment for many tissues, but the strongest enrichment was for brain tissue in the (a) ACC (blue) and (b) DLPFC (orange). Figure S18. Cis-edQTLs that co-localize with GWAS loci using coloc2 software. Associations between adjusted RNA editing levels and imputed genotype dosages for edQTLs that co-localize with SCZ GWAS risk loci in the ACC and DLPFC (brain regions are labeled accordingly; p-values were computed using linear regression and FDR adjustment from the R package matrixEQTL). The allelic effect of the SNPs on editing levels are shown by boxplots within violin plots. Violin plot shows the density plot of the data on each side, the lower and upper border of the box correspond to the first and third quartiles, respectively, the central line depicts the median, and whiskers extends from the borders to ±1.5xinter-quantile range, the distance between the first and third quantiles.
ME-Trait Relationships

